Kurs
+0,29%
Kalender
| Est. tid* | ||
| 2025-10-27 | 18:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-25 | 18:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-23 | 18:00 | Kvartalsrapport 2025-Q1 |
| 2025-04-24 | - | Årsstämma |
| 2025-04-12 | - | X-dag ordinarie utdelning DANCAN 0.00 DKK |
| 2025-02-24 | - | Split DANCAN 1000:1 |
| 2025-02-17 | - | Bokslutskommuniké 2024 |
| 2025-01-21 | - | Extra Bolagsstämma 2025 |
| 2024-12-10 | - | Extra Bolagsstämma 2024 |
| 2024-11-22 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-14 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-01 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-30 | - | Årsstämma |
| 2024-04-22 | - | X-dag ordinarie utdelning DANCAN 0.00 DKK |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-11-30 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-31 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-31 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-19 | - | X-dag ordinarie utdelning DANCAN 0.00 DKK |
| 2023-04-18 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-04 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-20 | - | Extra Bolagsstämma 2022 |
| 2022-08-31 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-18 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-27 | - | Årsstämma |
| 2022-04-08 | - | X-dag ordinarie utdelning DANCAN 0.00 DKK |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-11-26 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-07-23 | - | Extra Bolagsstämma 2021 |
| 2021-05-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-29 | - | X-dag ordinarie utdelning DANCAN 0.00 DKK |
| 2021-04-28 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
COPENHAGEN, Denmark, 27 March 2025
DanCann Pharma A/S' annual report 2024 was planned to be released on 31 March 2025, and the annual general meeting 2025 was planned to be held on 14 April 2025.
The release of the annual report 2024, the notice of the annual general meeting 2025 and the holding of the annual general meeting 2025 are postponed to the following dates:
| Release of annual report 2024 | 4 April 2025 |
| Notice of annual general meeting 2025 | 4 April 2025 |
| Annual general meeting 2025 | 24 April 2025 |
DanCann Pharma A/S' financial calendar has been updated accordingly.
For further information, please contact:
Jeppe Krog Rasmussen, CEO
E-mail: jkr@dancann.com
About DanCann Pharma A/S
DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids.
DanCann Pharma A/S (SS: DANCAN) is listed on the Spotlight Stock Market in Copenhagen/Stockholm.
For more information, visit: www.dancann.com